Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Predictive Proteomic Factors of the Response to Exclusive Concomitant Radiochemotherapy in Oesophageal Cancer

NCT00911092 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT00911092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00911092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Predictive Proteomic Factors of the Response to Exclusive Concomitant Radiochemotherapy in Oesophageal Cancer
Lead sponsor
Centre Oscar Lambret
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
December 31, 2011
Enrollment
50 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer